Human medicinehttps://www.ema.europa.eu/en/homepageHuman medicineen-gbCopyright: (C) European Medicines AgencySun, 02 Jun 2024 04:29:46 +0200Thu, 11 Apr 2024 15:48:00 +0200Human medicines European public assessment report (EPAR): Ozempic, semaglutide, Date of authorisation: 08/02/2018, Revision: 11, Status: Authorisedhttps://www.ema.europa.eu/en/medicines/human/EPAR/ozempicHuman medicines European public assessment report (EPAR): Ozempic, semaglutide, Date of authorisation: 08/02/2018, Revision: 11, Status: Authorisedhttps://www.ema.europa.eu/en/medicines/human/EPAR/ozempicThu, 11 Apr 2024 15:48:00 +0200Human medicineOzempic : EPAR - All Authorised presentationshttps://www.ema.europa.eu/system/files/documents/all-authorised-presentations/h-4174-aa_en.pdfOzempic : EPAR - All Authorised presentationshttps://www.ema.europa.eu/system/files/documents/all-authorised-presentations/h-4174-aa_en.pdfWed, 23 Feb 2022 02:00:00 +0100Human medicine